Related people
Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.
Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.
Adrian publishes and speaks regularly on a variety of intellectual property issues.
Since 2019 | Partner, Taylor Wessing |
2007 - 2019 | Partner, Eversheds Sutherland LLP |
2007 | Counsel, Boyes Turner |
1997 - 2007 | Managing Associate, Linklaters |
2000 | Post-Graduate Diploma, Intellectual Property Law and Practice, University of Bristol |
1997 | Bachelor of Laws, European Law, College of Europe, Bruges |
1994 | Master of Arts, Physics (First Class Honours), University of Oxford |
The International Association for the Protection of Intellectual Property The European Patent Lawyers Association |
Latest news & insights
Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million
by multiple authors
Seven steps to UPC readiness
by multiple authors
Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round
by Ross McNaughton and Adrian Toutoungi
Advising Placid0 on its acquisition by eyecare brand WALDO
by multiple authors